LONG-TERM IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION OVER 4 YEARS OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

被引：3
|
作者：
van der Heijde, D. [1 ]
Braun, J. [2 ]
Rudwaleit, M. [3 ]
Landewe, R. [4 ,5 ]
Purcaru, O. [6 ]
Kavanaugh, A. [7 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[2] Rheumazentrum Ruhrgebiet, Herne, Germany
[3] Endokrinologikum Berlin, Berlin, Germany
[4] Acad Med Ctr, Amsterdam, Netherlands
[5] Atrium Med Ctr, Heerlen, Netherlands
[6] UCB Pharma, Brussels, Belgium
[7] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, San Diego, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.3235
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0389
引用
收藏
页码：809 / 809
页数：1
相关论文
共 50 条
  • [1] LONG-TERM IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION OVER 4 YEARS OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
    van der Heijde, D.
    Braun, J.
    Rudwaleit, M.
    Landewe, R.
    Purcaru, O.
    Kavanaugh, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A546 - A546
  • [2] SUSTAINED IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION WITH CERTOLIZUMAB PEGOL OVER 96 WEEKS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
    van der Heijde, D.
    Braun, J.
    Rudwaleit, M.
    Purcaru, O.
    Kavanaugh, A.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A387 - A387
  • [3] Sustained Improvements in Workplace and Household Productivity and Social Participation with Certolizumab Pegol over 96 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis.
    van der Heijde, Desiree
    Braun, Juergen
    Rudwaleit, Martin
    Purcaru, Oana
    Kavanaugh, Arthur
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1119 - S1119
  • [4] Reduction Of Disease Burden On Workplace and Household Productivity In Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis, Over 48 Weeks Of Treatment With Certolizumab Pegol
    van der Heijde, Desiree M.
    Braun, Juergen
    Rudwaleit, Martin
    Purcaru, Oana
    Kavanaugh, Arthur
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S644 - S645
  • [5] Effect Of Certolizumab Pegol Over 48 Weeks In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Landewe, Robert B. M.
    Rudwaleit, Martin
    van der Heijde, Desiree M.
    Dougados, Maxime
    Mease, Philip J.
    Reveille, John D.
    Walsh, Jessica
    Kivitz, Alan J.
    Maksymowych, Walter P.
    Braun, Juergen
    Deodhar, Atul A.
    Stach, Christian
    Hoepken, Bengt
    Singh, Pritibha
    Sieper, Joachim
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S767 - S767
  • [6] Effect of Certolizumab Pegol Over 48 Weeks in Patients with Axial Spondyloarthritis, including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Maksymowych, Walter
    Landewe, Robert
    Rudwaleit, Martin
    van der Heijde, Desiree
    Dougados, Maxime
    Mease, Phillip
    Reveille, John
    Walsh, Jessica
    Kivitz, Alan
    Braun, Juergen
    Deodhar, Atul
    Stach, Christian
    Hoepken, Bengt
    Singh, Pritibha
    Sieper, Joachim
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1496 - 1497
  • [7] Safety and Efficacy of Certolizumab Pegol over 204 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Deodhar, Atul A.
    Dougados, Maxime
    Landewe, Robert
    Sieper, Joachim
    Maksymowych, Walter
    Rudwaleit, Martin
    van Den Bosch, Filip
    Braun, Juergen
    Mease, Philip J.
    Kivitz, Alan
    Walsh, Jessica
    Davies, Owen
    Hoepken, Bengt
    Peterson, Luke
    van der Heijde, Desiree
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] Safety and Efficacy of Certolizumab Pegol over 96 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis.
    Sieper, Joachim
    Rudwaleit, Martin
    van der Heijde, Desiree M.
    Maksymowych, Walter P.
    Dougados, Maxime
    Mease, Philip
    Braun, Juergen
    Deodhar, Atul A.
    Hoepken, Bengt
    Nurminen, Tommi
    Landewe, Robert B. M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S376 - S377
  • [9] CONTINUED IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY WITH CERTOLIZUMAB PEGOL TREATMENT IN AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 48-WEEK RESULTS FROM THE RAPID-AXSPA STUDY
    van der Heijde, D.
    Braun, J.
    Rudwaleit, M.
    Purcaru, O.
    Kavanaugh, A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A570 - A570
  • [10] Four Year Imaging Outcomes in Patients with Axial Spondyloarthritis Treated with Certolizumab Pegol, Including Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    van der Heijde, Desiree
    Baraliakos, Xenofon
    Hermann, Kay-Geert
    Landewe, Robert
    Machado, Pedro
    Maksymowych, Walter
    Davies, Owen
    de Peyrecave, Natasha
    Hoepken, Bengt
    Bauer, Lars
    Nurminen, Tommi
    Braun, Juergen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345